← FDA Drug Approvals (Drugs@FDA)

ELEPSIA XR

NDA · New Drug Application · Sponsor: TRIPOINT · Approved 2018-12-20

Drug application

FDA Application #

NDA204417

Application type

New Drug Application

Brand name

ELEPSIA XR

Generic name

LEVETIRACETAM

Active ingredients

LEVETIRACETAM

Dosage form

TABLET, EXTENDED RELEASE

Route

ORAL

Marketing status

Discontinued

Sponsor

TRIPOINT

Manufacturer

TRIPOINT THERAPEUTICS, LLC

First approval

2018-12-20

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown